Recursion Pharmaceuticals news
The latest Recursion Pharmaceuticals news, : Medical AI expands into rare‑disease drug discovery and virtual lab markets.
2 stories mentioning Recursion Pharmaceuticals since 23 September 2026, newest first, each with its sources and discussion. Follow to see new ones on your front page.
-
Medical AI expands into rare‑disease drug discovery and virtual lab markets
DeepMind’s AlphaFold has predicted more than 200 million protein structures, giving AI‑driven drug discovery startups a large data foundation. Recursion Pharmaceuticals, a US biotech, reports encouraging Phase 1b/2…
1 sourceUnite.AI -
Enveda raises $311 million Series E to advance nature-derived AI drugs
Enveda, a biotech startup that applies artificial intelligence to discover medicines from plants and microbes, announced a $311 million Series E financing round. The round was led by Catalio Capital Management with…
1 sourceTechCrunch AI
Questions about Recursion Pharmaceuticals
What is the latest Recursion Pharmaceuticals news?
As of 20 October 2026: Medical AI expands into rare‑disease drug discovery and virtual lab markets. DeepMind’s AlphaFold has predicted more than 200 million protein structures, giving AI‑driven drug discovery startups a large data foundation.